Article
Molecular pathogenesis of long QT syndrome type 2
22 Jan 2016
Abstract excerpt
Abstract The molecular mechanisms underlying congenital long QT syndrome (LQTS) are now beginning to be understood. New insights into the etiology and therapeutic strategies are emerging from heterologous expression studies of LQTS‐linked mutant proteins, as well as inducible pluripotent stem cell derived cardiomyocytes (iPSC‐CMs) from LQTS patients. This review focuses on the major molecular mechanism that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
